Corporate News     25-May-22
Natco Pharma update on lawsuit for Glatiramer Acetate Injection
Natco Pharma announced that Johnson & Johnson's and Momenta Pharmaceuticals has filed a lawsuit against NATCO and its marketing partner Mylan Pharmaceuticals Inc. (Mylan) & others alleging infringement of two old Patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate Injection.

This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner, Mylan believe this is a meritless suit for a product that has been in the market for more than 5 years. Mylan and NATCO will strongly defend against this suit.

Previous News
  Natco Pharma
 ( Results - Analysis 15-Nov-23   14:30 )
  Indices turn rangebound; metal shares slide; VIX rises 3.93%
 ( Market Commentary - Mid-Session 04-Sep-24   12:36 )
  Natco Pharma Ltd rises for third consecutive session
 ( Hot Pursuit - 24-Jul-24   13:05 )
  Natco Pharma Ltd spurts 1.79%
 ( Hot Pursuit - 26-Dec-23   13:05 )
  Board of Natco Pharma recommends Second Interim Dividend
 ( Corporate News - 16-Nov-23   09:39 )
  Natco Pharma Ltd eases for fifth straight session
 ( Hot Pursuit - 15-Mar-23   13:35 )
  Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
 ( Corporate News - 04-Sep-24   12:07 )
  Natco Pharma fixes record date for 2nd interim dividend
 ( Market Beat - Reports 11-Nov-21   18:38 )
  Natco Pharma
 ( Results - Analysis 30-May-23   11:27 )
  Natco Pharma Ltd soars 1.76%, Gains for third straight session
 ( Hot Pursuit - 08-Aug-24   13:05 )
  Natco Pharma to conduct board meeting
 ( Corporate News - 06-Nov-23   15:32 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top